COSCIENS Biopharma (AEZS) Revenue & Revenue Breakdown
COSCIENS Biopharma Revenue Highlights
Latest Revenue (Y)
$4.58M
Latest Revenue (Q)
$3.98K
Main Geography (Y)
Denmark
COSCIENS Biopharma Revenue by Period
COSCIENS Biopharma Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $4.58M | -18.79% |
| 2022-12-31 | $5.64M | 7.22% |
| 2021-12-31 | $5.26M | 44.03% |
| 2020-12-31 | $3.65M | 586.47% |
| 2019-12-31 | $532.00K | -98.02% |
| 2018-12-31 | $26.88M | 2812.35% |
| 2017-12-31 | $923.00K | 1.32% |
| 2016-12-31 | $911.00K | 67.16% |
| 2015-12-31 | $545.00K | 4854.55% |
| 2014-12-31 | $11.00K | -99.82% |
| 2013-12-31 | $6.17M | -81.66% |
| 2012-12-31 | $33.66M | -6.62% |
| 2011-12-31 | $36.05M | 30.14% |
| 2010-12-31 | $27.70M | -56.19% |
| 2009-12-31 | $63.24M | 64.35% |
| 2008-12-31 | $38.48M | -8.53% |
| 2007-12-31 | $42.07M | 1.63% |
| 2006-12-31 | $41.39M | -83.27% |
| 2005-12-31 | $247.39M | 27.50% |
| 2004-12-31 | $194.03M | 51.20% |
| 2003-12-31 | $128.33M | 99.63% |
| 2002-12-31 | $64.28M | 133.77% |
| 2001-12-31 | $27.50M | 390.57% |
| 2000-12-31 | $5.61M | 31.84% |
| 1999-12-31 | $4.25M | 52.14% |
| 1998-12-31 | $2.79M | -37.52% |
| 1997-12-31 | $4.47M | 118.89% |
| 1996-12-31 | $2.04M | - |
COSCIENS Biopharma generated $4.58M in revenue during NA 2023, up -18.79% compared to the previous quarter, and up 17.04% compared to the same period a year ago.
COSCIENS Biopharma Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-03-31 | $3.98K | -96.80% |
| 2023-12-31 | $124.34K | 4044.80% |
| 2023-09-30 | $3.00K | -99.87% |
| 2023-06-30 | $2.25M | 5.55% |
| 2023-03-31 | $2.13M | -14.37% |
| 2022-12-31 | $2.48M | 33.60% |
| 2022-09-30 | $1.86M | -937.84% |
| 2022-06-30 | $-222.00K | -114.63% |
| 2022-03-31 | $1.52M | 58.68% |
| 2021-12-31 | $956.00K | 58.80% |
| 2021-09-30 | $602.00K | 0.50% |
| 2021-06-30 | $599.00K | 2.22% |
| 2021-03-31 | $586.00K | -75.23% |
| 2020-12-31 | $2.37M | 1748.44% |
| 2020-09-30 | $128.00K | 88.24% |
| 2020-06-30 | $68.00K | -93.76% |
| 2020-03-31 | $1.09M | 5955.56% |
| 2019-12-31 | $18.00K | -93.64% |
| 2019-09-30 | $283.00K | 45.88% |
| 2019-06-30 | $194.00K | 424.32% |
| 2019-03-31 | $37.00K | -97.34% |
| 2018-12-31 | $1.39M | 109.95% |
| 2018-09-30 | $663.00K | 294.64% |
| 2018-06-30 | $168.00K | -99.32% |
| 2018-03-31 | $24.66M | 13752.81% |
| 2017-12-31 | $178.00K | -26.14% |
| 2017-09-30 | $241.00K | -0.82% |
| 2017-06-30 | $243.00K | -6.90% |
| 2017-03-31 | $261.00K | -14.14% |
| 2016-12-31 | $304.00K | 13.01% |
| 2016-09-30 | $269.00K | 180.21% |
| 2016-06-30 | $96.00K | -60.33% |
| 2016-03-31 | $242.00K | 137.25% |
| 2015-12-31 | $102.00K | -41.04% |
| 2015-09-30 | $173.00K | -12.18% |
| 2015-06-30 | $197.00K | 169.86% |
| 2015-03-31 | $73.00K | 563.64% |
| 2014-12-31 | $11.00K | 100.00% |
| 2014-09-30 | - | 100.00% |
| 2014-06-30 | - | 100.00% |
| 2014-03-31 | - | -100.00% |
| 2013-12-31 | $-61.57M | -392.37% |
| 2013-09-30 | $21.06M | -30.01% |
| 2013-06-30 | $30.09M | 81.26% |
| 2013-03-31 | $16.60M | 73.90% |
| 2012-12-31 | $9.54M | 33.70% |
| 2012-09-30 | $7.14M | -4.44% |
| 2012-06-30 | $7.47M | -21.44% |
| 2012-03-31 | $9.51M | -24.69% |
| 2011-12-31 | $12.63M | 32.72% |
| 2011-09-30 | $9.51M | 45.85% |
| 2011-06-30 | $6.52M | -11.72% |
| 2011-03-31 | $7.39M | -25.90% |
| 2010-12-31 | $9.97M | 74.14% |
| 2010-09-30 | $5.73M | 2.54% |
| 2010-06-30 | $5.58M | -13.05% |
| 2010-03-31 | $6.42M | -84.02% |
| 2009-12-31 | $40.18M | 369.14% |
| 2009-09-30 | $8.56M | 2.22% |
| 2009-06-30 | $8.38M | 37.11% |
| 2009-03-31 | $6.11M | -15.64% |
| 2008-12-31 | $7.24M | -34.32% |
| 2008-09-30 | $11.03M | 5.47% |
| 2008-06-30 | $10.46M | 7.34% |
| 2008-03-31 | $9.74M | 17.87% |
| 2007-12-31 | $8.27M | -28.77% |
| 2007-09-30 | $11.60M | - |
COSCIENS Biopharma generated $3.98K in revenue during Q1 2024, up -96.80% compared to the previous quarter, and up 0.16% compared to the same period a year ago.
COSCIENS Biopharma Revenue Breakdown
COSCIENS Biopharma Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 19 | Dec 18 |
|---|---|---|
| Denmark | $413.00K | - |
| Ireland | $74.00K | - |
| Other | $45.00K | - |
| CHINA | - | $275.00K |
Latest
COSCIENS Biopharma's latest annual revenue breakdown by geography, as of Dec 19: Denmark (77.63%), Ireland (13.91%), and Other (8.46%).
COSCIENS Biopharma Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| ONTX | Traws Pharma | $226.00B | $56.00K |
| JAGX | Jaguar Health | $9.76M | $3.07M |
| TNXP | Tonix Pharmaceuticals | $7.77M | $2.82M |
| PULM | Pulmatrix | $7.30M | $366.00K |
| AEZS | COSCIENS Biopharma | $4.58M | $3.98K |
| CBIO | Gyre Therapeutics | $794.00K | - |
| ADTX | Aditxt | $645.18K | $44.28K |
| BPTH | Bio-Path | - | - |
| RVPH | Reviva Pharmaceuticals | - | - |
| MBRX | Moleculin Biotech | - | - |
| ADIL | Adial Pharmaceuticals | - | - |
| ATXI | Avenue Therapeutics | - | - |
| RNAZ | TransCode Therapeutics | - | - |
| DFFN | CervoMed | - | - |
| ACST | Acasti Pharma | - | - |